HT Pharmaceuticals Clinical Research Consulting Humphrey Tebit, Principal.

Slides:



Advertisements
Similar presentations
Opera: presentation December, 10th 2009
Advertisements

Our Vision:- We; Jupiter Research Services; are a Clinical Research Service provider, providing the core clinical research services like site management,
Gakava L Roche Products Ltd., Welwyn, UK
Project Quality Plans Gillian Sandilands Director of Quality
6th European Patients’ Rights Day The EMA Geriatric Medicines Strategy and the empowered aging patient Francesca Cerreta EMA (European Medicines Agency)
MICS4 Survey Design Workshop Multiple Indicator Cluster Surveys Survey Design Workshop The MICS4 Process.
CenterWatchs Flagship Publication. The CenterWatch Monthly Launched 15 years ago to provide proprietary data and information about the then budding clinical.
Want to SAVE a Few Million Dollars?. Give Us the OPPORTUNITY Do Just That and Well.
1 WORKSHOP 4: KEY COMMENTS FROM THE PANEL DISCUSSION The 3rd Kitasato University - Harvard School of Public Health Symposium Wednesday October 2nd - Thursday.
Bioprocess Pilot Facility
Create division of responsibilities document Submit sponsorship application Register project with R&I Add reference number to spreadsheet Allocate study.
The Clinical and Pharmaceutical Recruitment People.
TAKE Solutions Enabling Business Efficiencies Ram Yeleswarapu President & CEO Analysts Meet Mumbai September 18, 2008.
Organisational Readiness Self Assessment (ORSA) Analysis 2012/13 submissions – Area Teams Revalidation Forum 18 th September 2013 NHS | Presentation to.
Medical Science Liaison Clinical Science Liaison BY: Jamar G.
Working in and career progression within an academic clinical trials unit Helen Thorpe Principal Statistician Clinical Trials Research Unit (CTRU) University.
1/16 Service Package for Life Science Start-Ups Regulatory, Reimbursement, Quality and Clinical Research In Europe and the USA UK Office: 27 Old Gloucester.
VALIDATION OF COMPUTERISED SYSTEMS IN THE PHARMACEUTICAL INDUSTRY Matt Safi Product manager.
The Statisticians Role in Pharmaceutical Development
An introduction to Medical Communications
EDC PHARMA SERVICES Capacity. Expertise. Solutions. Technology.
Genomics Commercialization Glen Schuler Managing Director, Industry Liaison Office University of Saskatchewan.
| LUMIS International GmbH | Successful conduct of clinical trials to prove biosimilarity through defining a best fit outsourcing strategy Heike Schoen,
Consulting for Life Sciences 1 Confidential October 14, 2014 Strategic Science and Technology Capabilities Discussion
By Saurabh Sardesai October 2014.
1 Proposed PLCS TC Organization and Functional Responsibilities Revision
Career Opportunities for PharmDs in the Pharmaceutical Industry: Research & Development.
ZHRC/HTI Financial Management Training
Training Workshop on Pharmaceutical Development with a Focus on Paediatric Medicines / October |1 | Regulatory Requirement on Dossier of Medicinal.
Healing Hands Clinical Research Services is a clinical Research Service Provider which has broad spectrum of.
Healing Hands Clinical Research Services is a Site Management organization with broad spectrum of activities.
Medical Research BADRAG meeting Jan 2013 Dr H Sari-Kouzel.
Protocol Complexity as a Factor in Vendor Management Compliance Risk
The company of specialists. What are the global trends that we are seeing in Statistics and Programming? How does this impact our roles?
Contracts: Negotiations and Key Elements Belinda Vandersluis Operations Director, NCIC CTG.
Good Clinical Practice (GCP)- An introduction Dr Noor Ibrahim Mohamed Sakian.
Access to Clinical Expertise Steve Bain David Powell Jemma Hughes Paula Jeffries.
Target Institute of Medical Education & Research (TIMER) Provides Clinical Research services to Pharmaceutical, Biotechnology product companies right.
Partnering with Pharmaceutical Leaders Active in Clinical Research
INTRODUCTION TO RA.
Introduction to The Cmed Group. About Cmed 2 Cmed Group Cmed Group is an innovative clinical trials services and advanced software provider that includes.
Stakeholders In Clinical Research The Pharma Company Professor Phil Warner.
Second Annual Japan CDISC Group (JCG) Meeting 28 January 2004 Julie Evans Director, Technical Services.
 Founded in August 2009, in Nanjing, China  SFDA GLP and AAALAC certified DMPK CRO company  GLP bioanalytical support for small and macro molecule,
SIPLAS RO is a full service contract research organization CRO, offering nanotechnology, biopharmaceutical and medical device companies comprehensive.
MEDICAL experts INDUSTRY Some of our clients. Pharmaceutical companies, manufacturers of medical and surgical devices, clinical research organizations,
Case Study SummaryChallenges Boston Scientific needed medical translation in different areas in the medical field, including technical, legal and corporate.
CLINICAL TRIALS IN NEW DRUG DEVELOPMENT Michael A Ross,M.D. President CPL Inc.
Molecule-to-Market-Place Quality
Global Sage Group GSG Overview Talking Points. Talking Points Global Sage Group 11/18/ Value Proposition Only experienced practitioners –Add value.
ISPE Central Canada Chapter Annual Meeting September 28, 2006 Yvon R. Tessier Pharmaceutical contract manufacturing challenges.
FDA Standards Development and Implementation Randy Levin, M.D. Director, Office of Information Management Center for Drug Evaluation and Research Food.
International Partnership for Microbicides Approach to HIV Treatment and Care in Future IPM Microbicide Trials Pam Norick, Chief of External Relations.
Regulatory Submissions to Asian Countries DIA MW All-SIAC Telecon Thursday 06 May :00 AM (PDT)
QAA COLLABORATIVE PROVISION AUDIT DRAFT REPORT. QAA CPA Process Submission by the University of Self Evaluation Document (SED) (December 2005) Selection.
© Coherent market Insights. All Rights Reserved PEDIATRIC CLINICAL TRIALS MARKET Global Industry Insights, Outlook Size, Share and Opportunity Analysis,
Responsibilities of Sponsor, Investigator and Monitor
OUS Data: What does the CE Mark Really Mean?
EAST AFRICAN COMMUNITY MEDICINES REGULATORY HARMONIZATION (EAC-MRH) PROJECT PROGRESS NAIROB I - KENYA By: EAC - Secretariat.
ICH-GCP Avinash Kondawar M. Pharm Lead CRA
LNH Pharma A Trusted Partner.
How to Apply for and Receive Industry Funding for Investigator Sponsored Research Chuck Simonton MD, FACC, FSCAI Chief Medical Officer Abbott Vascular.
To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the screen changes and you.
To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the screen changes and you.
Minor Uses A North American Perspective
MEDICAL PLASTICS MARKET Industry Survey, Growth, Competitive Landscape and Forecasts to 2023 PREPARED BY Market Research Future (Part of Wantstats.
SMART POLYMERS MARKET FORECAST 2018 TO 2023 Industry Survey, Growth, Competitive Landscape and Forecasts to 2023 PREPARED BY Market Research Future (Part.
Infrastructural Support – Enabling CTS
PAI Preparation and Readiness
Pediatric Medical Device Market is expected to grow at a CAGR of approximately 10.5% during the forecast period PREPARED BY Market Research Future.
Presentation transcript:

HT Pharmaceuticals Clinical Research Consulting Humphrey Tebit, Principal

Copyright © 2009 All Rights Reserved HT Pharmaceuticals Company History HT Pharmaceuticals registered as a Sole Proprietorship in 2008 HT Pharmaceuticals registered as a Sole Proprietorship in 2008 Invited to conduct a pilot study for a small pharmaceutical company in March 2008 Invited to conduct a pilot study for a small pharmaceutical company in March 2008 Selected to work on projects for two different Contract Research Organizations (CROs) in 2008 Selected to work on projects for two different Contract Research Organizations (CROs) in 2008 Currently working on 3 pivotal studies for a small pharmaceutical company, due for submission to Health Canada by the end of 2009 Currently working on 3 pivotal studies for a small pharmaceutical company, due for submission to Health Canada by the end of 2009

Copyright © 2009 All Rights Reserved HT Pharmaceuticals Humphrey Tebit, Principal M.Sc. in Biometry (Applied Statistics) M.Sc. in Biometry (Applied Statistics) B.Sc. (Hons) Biochemistry B.Sc. (Hons) Biochemistry 15 years of pharmaceutical experience, 10 in Europe and 5 in North America 15 years of pharmaceutical experience, 10 in Europe and 5 in North America 4 years of scientific experience in Africa 4 years of scientific experience in Africa

Copyright © 2009 All Rights Reserved HT Pharmaceuticals Industry Experience Associate Director Pharmacokinetics and Statistics, Biovail Contract Research Associate Director Pharmacokinetics and Statistics, Biovail Contract Research Director of Pharmaceutics, Cantest Director of Pharmaceutics, Cantest Clinical Development Consultant, Apotex Clinical Development Consultant, Apotex Clinical Consultant, Genpharm Clinical Consultant, Genpharm Senior Biometrics Officer and Team Leader, Merck Generics (UK) Senior Biometrics Officer and Team Leader, Merck Generics (UK) Research Assistant, Animal Research Institute Research Assistant, Animal Research Institute

Copyright © 2009 All Rights Reserved HT Pharmaceuticals Key Strengths Full understanding of clinical trials Full understanding of clinical trials Broad and varied technical skills required for project management Broad and varied technical skills required for project management Effective liaison among product manufacturers, sponsor companies, CRO’s and sub-contractors Effective liaison among product manufacturers, sponsor companies, CRO’s and sub-contractors Excellent communication and presentation skills Excellent communication and presentation skills International experience to manage study activities for global companies International experience to manage study activities for global companies

Copyright © 2009 All Rights Reserved HT Pharmaceuticals Services Offered Research & Planning Research & Planning CRO Selection & Management CRO Selection & Management Study Management Study Management Submission Submission

Copyright © 2009 All Rights Reserved HT Pharmaceuticals Research & Planning Conducting feasibility studies for submission Conducting feasibility studies for submission Reviewing results to date to determine study design parameters for future studies Reviewing results to date to determine study design parameters for future studies Designing Phase I - Phase III studies Designing Phase I - Phase III studies Consulting with relevant regulatory bodies Consulting with relevant regulatory bodies Managing Pharmacokinetics BA/BE studies Managing Pharmacokinetics BA/BE studies –Designing PK studies for both BA and BE type studies –Applying understanding of PK/TK parameters to study design and interpretation of results

Copyright © 2009 All Rights Reserved HT Pharmaceuticals CRO Selection & Management CRO selection CRO selection –Applying experience working with over 50 CROs to identify those capable of conducting the studies –Obtaining quotes from multiple CROs to determine the best CRO for the project and manage costs Development of bioanalytical methods Development of bioanalytical methods –Advising on method development to ensure correlation between study designs and bioanalytical methods –Ensuring maximum study data capture Liaise between product manufacturers and study implementation CRO Liaise between product manufacturers and study implementation CRO Resolve study technical issues between CRO and pharmaceutical company Resolve study technical issues between CRO and pharmaceutical company

Copyright © 2009 All Rights Reserved HT Pharmaceuticals Study Management Apply clinical research experience to manage project activities efficiently and effectively Apply clinical research experience to manage project activities efficiently and effectively Analysis of clinical data Analysis of clinical data Study report review and report writing Study report review and report writing –Interpreting and presenting statistical study results to non-statisticians –Writing reports for different regulatory jurisdictions

Copyright © 2009 All Rights Reserved HT Pharmaceuticals Submission Advise on submission strategy Advise on submission strategy Review submission package and provide all required documentation Review submission package and provide all required documentation Interpret unexpected results and demonstrate relevance for submission and/or for planning future studies Interpret unexpected results and demonstrate relevance for submission and/or for planning future studies

Copyright © 2009 All Rights Reserved HT Pharmaceuticals Completed BE Pilot Study Supporting a small size pharma company on their Abbreviated New Drug Submission (ANDS) into Health Canada Supporting a small size pharma company on their Abbreviated New Drug Submission (ANDS) into Health Canada Pilot Study activities Pilot Study activities –Designed study –Obtained quotes from 3 CROs, selected the most suitable CRO for study and contracted out the work –Significant input into the study protocol and development of study documentation –Managed study activities from pre-study through clinical and bioanalytical phases to report review

Copyright © 2009 All Rights Reserved HT Pharmaceuticals Current BE Study Three Pivotal Studies: Three Pivotal Studies: –Performed all Pilot Study activities –Saved company over $100K on each study by selecting the best CRO and the most cost effective study design –Monitored Phase I of clinical phase of study Writing controlled correspondence for the company on study requirements Writing controlled correspondence for the company on study requirements Liaison with European product manufacturer on documentation required for study protocol approval Liaison with European product manufacturer on documentation required for study protocol approval

Copyright © 2009 All Rights Reserved HT Pharmaceuticals Client Feedback Current client is very satisfied with the way HT Pharmaceuticals is handling their study activities Current client is very satisfied with the way HT Pharmaceuticals is handling their study activities Client has given total control and responsibility of running the studies to HT Pharmaceuticals Client has given total control and responsibility of running the studies to HT Pharmaceuticals Client has consulted HT Pharmaceuticals on additional projects Client has consulted HT Pharmaceuticals on additional projects

Copyright © 2009 All Rights Reserved HT Pharmaceuticals Why Work with HT Pharmaceuticals HT Pharmaceuticals can: Support your study requirements for a more efficient and successful submission Support your study requirements for a more efficient and successful submission Provide you with expert advice on technical issues for clinical trials Provide you with expert advice on technical issues for clinical trials Apply European and North American experience to support global implementation of clinical trials Apply European and North American experience to support global implementation of clinical trials Manage all your study activities and work independently with the CRO to assure a successful outcome Manage all your study activities and work independently with the CRO to assure a successful outcome